These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 30053213)
21. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era. Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327 [TBL] [Abstract][Full Text] [Related]
22. Comparison of intraoperative fluorescence and MRI image guided neuronavigation in malignant brain tumours, a prospective controlled study. Eljamel S; Petersen M; Valentine R; Buist R; Goodman C; Moseley H; Eljamel S Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):356-61. PubMed ID: 24284085 [TBL] [Abstract][Full Text] [Related]
23. Beyond fluorescence-guided resection: 5-ALA-based glioblastoma therapies. Stummer W; Müther M; Spille D Acta Neurochir (Wien); 2024 Apr; 166(1):163. PubMed ID: 38563988 [TBL] [Abstract][Full Text] [Related]
24. Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up. Della Puppa A; Lombardi G; Rossetto M; Rustemi O; Berti F; Cecchin D; Gardiman MP; Rolma G; Persano L; Zagonel V; Scienza R J Neurooncol; 2017 Jan; 131(2):331-340. PubMed ID: 27757721 [TBL] [Abstract][Full Text] [Related]
25. 5-ALA in the management of malignant glioma. Stepp H; Stummer W Lasers Surg Med; 2018 Jul; 50(5):399-419. PubMed ID: 29737540 [TBL] [Abstract][Full Text] [Related]
26. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up. Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914 [TBL] [Abstract][Full Text] [Related]
27. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation. Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129 [TBL] [Abstract][Full Text] [Related]
28. Photodynamic Therapy for the Treatment of Glioblastoma. Cramer SW; Chen CC Front Surg; 2019; 6():81. PubMed ID: 32039232 [TBL] [Abstract][Full Text] [Related]
36. Photodynamic diagnosis and therapy and the brain. Kostron H Methods Mol Biol; 2010; 635():261-80. PubMed ID: 20552352 [TBL] [Abstract][Full Text] [Related]
37. A novel device for intraoperative photodynamic therapy dedicated to glioblastoma treatment. Dupont C; Mordon S; Deleporte P; Reyns N; Vermandel M Future Oncol; 2017 Nov; 13(27):2441-2454. PubMed ID: 28942677 [TBL] [Abstract][Full Text] [Related]
38. 5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells. Karmakar S; Banik NL; Patel SJ; Ray SK Neurosci Lett; 2007 Mar; 415(3):242-7. PubMed ID: 17335970 [TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia. Kohoutova D; Haidry R; Banks M; Butt MA; Dunn J; Thorpe S; Lovat L Scand J Gastroenterol; 2018 May; 53(5):527-532. PubMed ID: 29161901 [TBL] [Abstract][Full Text] [Related]
40. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Pass HI; Temeck BK; Kranda K; Thomas G; Russo A; Smith P; Friauf W; Steinberg SM Ann Surg Oncol; 1997 Dec; 4(8):628-33. PubMed ID: 9416409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]